Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

April 25 (Bloomberg) -- Baker Hughes Inc., the oilfield services company, is breaking with industry practice in saying it will disclose all the chemicals it uses for hydraulic fracturing.

Its objectives in letting go of trade secret claims is achieving “a balance that increases public trust while encouraging commercial innovation,” the Houston-based company said on its website. Complete lists of the products and chemical in its fracking fluid will be made available, the company said.

Baker Hughes said it endorses FracFocus, the national hydraulic fracturing chemical registry managed by the Groundwater Protection Council and the Interstate Oil and Gas Compact Commission.


Sony Seeking U.S. Patent on Biometric-Analyzer Game Controller

Sony Corp., maker of the PlayStation game console, is seeking to patent a technology that will extract information about the emotional state of the player of an electronic game, with the aim of adapting the game to that state.

According to application 20140112556, which was issued yesterday, the invention includes sensors that can measure facial expressions, head poses, sound levels and semantic content of speech, skin moisture level, strength of the player’s grip on an object, the player’s depth and pace of breath, and even the level of hormones and enzymes in saliva.

Tokyo-based Sony applied for the patent in October 2012, according to the database of the U.S. Patent and Trademark Office.

Actavis to Sell Generic Celebrex After Settlement With Pfizer

Actavis Plc said it will be able to sell a generic form of Pfizer Inc.’s arthritis drug Celebrex after the companies settled a patent dispute.

Under the agreement, which follows the March 12 invalidation of a related patent, Pfizer will license Actavis to market the generic beginning in December, according to a statement yesterday. Actavis said it may be able to start selling the drug earlier, depending on circumstances it didn’t disclose.

The agreement is contingent on Actavis receiving approval from the U.S. Food and Drug Administration for its version of the drug. Actavis said earlier that it might begin selling generic Celebrex in May, subject to regulatory approval.

The case is G.D. Searle LLC v. Lupin Pharmaceuticals Inc., 13-cv-00121, U.S. District Court, Eastern District of Virginia (Norfolk).

For more patent news, click here.


LG Files Application to Register ‘W Watch’ as U.S. Trademark

LG Electronics Inc. filed an application to register “W Watch” as a U.S. trademark, according to the database of the U.S. Patent and Trademark Office.

The Korean electronics company said in its April 18 application that it intends to use the term with smartphones, including those in glasses and wristbands.

The mark will also be used for pulse and heartbeat measuring devices, and well as tablet computers and clocks, according to the application.

Ohio State’s Trademarks Infringed by T-Shirt Company, Court Says

Skreened Ltd., an Ohio-based print-on-demand clothing company, was found to have infringed trademarks belonging to Ohio State University.

A federal court in Columbus, Ohio, rejected what it said was the clothing company’s “attempt to cloak themselves in the First Amendment” by claiming its use of images was permitted free speech.

“Selling knockoffs is selling knockoffs,” the court said, ordering Skreened to quit using any Ohio State trademarks or any words or symbols that suggest an affiliation with the school.

The case is Ohio State University v. Skreened Ltd., 2:12-cv-00663, U.S. District Court, Southern District of Ohio (Columbus).

For more trademark news, click here.


Gawker Wins Dismissal of Tarantino Copyright Infringement Suit

Gawker Media LLC persuaded a federal court to dismiss a copyright infringement suit brought by movie director Quentin Tarantino in January.

Tarantino claimed Gawker infringed his copyrights to the screenplay for the film “The Hateful Eight” and that he had to abandon his plans to make the film after the script was leaked.

Gawker countered that its posting of links to the script fell under the law’s “fair use” exception for news reporting.

The court said April 22 that while Gawker’s argument was premature, the director failed to make a claim of contributory infringement against the celebrity-gossip website.

The case is Tarantino v. Gawker Media LLC, 14-cv-00603, U.S. District Court, Central District of California (Los Angeles).

For more copyright news, click here.

To contact the reporter on this story: Victoria Slind-Flor in San Francisco at

To contact the editors responsible for this story: Michael Hytha at Fred Strasser, Charles Carter

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.